Literature DB >> 16735690

Contemporary use of digoxin in the management of cardiovascular disorders.

Mihai Gheorghiade1, Dirk J van Veldhuisen, Wilson S Colucci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16735690     DOI： 10.1161/CIRCULATIONAHA.105.560110

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  49 in total

1.  Low-Dose Digoxin and Reduction in Mortality and Morbidity in Heart Failure.

Authors:  Ali Ahmed; Finn Waagstein
Journal:  Int J Cardiol       Date:  2009-07-24       Impact factor: 4.164

Review 2.  The vulnerable phase after hospitalization for heart failure.

Authors:  Stephen J Greene; Gregg C Fonarow; Muthiah Vaduganathan; Sadiya S Khan; Javed Butler; Mihai Gheorghiade
Journal:  Nat Rev Cardiol       Date:  2015-02-10       Impact factor: 32.419

Review 3.  Monitoring in clinical biochemistry.

Authors:  Jenny Doust; Paul Glasziou
Journal:  Clin Biochem Rev       Date:  2013-08

Review 4.  The Molecular Basis of Toxins' Interactions with Intracellular Signaling via Discrete Portals.

Authors:  Adi Lahiani; Ephraim Yavin; Philip Lazarovici
Journal:  Toxins (Basel)       Date:  2017-03-16       Impact factor: 4.546

5.  Acute heart failure with low cardiac output: can we develop a short-term inotropic agent that does not increase adverse events?

Authors:  Umberto Campia; Savina Nodari; Mihai Gheorghiade
Journal:  Curr Heart Fail Rep       Date:  2010-09

Review 6.  Signaling mechanisms that link salt retention to hypertension: endogenous ouabain, the Na(+) pump, the Na(+)/Ca(2+) exchanger and TRPC proteins.

Authors:  Mordecai P Blaustein; John M Hamlyn
Journal:  Biochim Biophys Acta       Date:  2010-03-06

7.  The cardiotonic steroid hormone marinobufagenin induces renal fibrosis: implication of epithelial-to-mesenchymal transition.

Authors:  Larisa V Fedorova; Vanamala Raju; Nasser El-Okdi; Amjad Shidyak; David J Kennedy; Sandeep Vetteth; David R Giovannucci; Alexei Y Bagrov; Olga V Fedorova; Joseph I Shapiro; Deepak Malhotra
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-28

8.  Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure.

Authors:  Robert C Bourge; Jerome L Fleg; Gregg C Fonarow; John G F Cleland; John J V McMurray; Dirk J van Veldhuisen; Mihai Gheorghiade; Kanan Patel; Inmaculada B Aban; Richard M Allman; Connie White-Williams; Michel White; Gerasimos S Filippatos; Stefan D Anker; Ali Ahmed
Journal:  Am J Med       Date:  2013-03-12       Impact factor: 4.965

9.  Anti-digoxin Fab variants generated by phage display.

Authors:  Viviane Midori Murata; Mariana Costa Braga Schmidt; Jorge Kalil; Lilian Rumi Tsuruta; Ana Maria Moro
Journal:  Mol Biotechnol       Date:  2013-06       Impact factor: 2.695

Review 10.  Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond.

Authors:  John R Teerlink; Marco Metra; Valerio Zacà; Hani N Sabbah; Gadi Cotter; Mihai Gheorghiade; Livio Dei Cas
Journal:  Heart Fail Rev       Date:  2009-12       Impact factor: 4.214
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.